Healthpeak Properties, Inc. (NYSE:DOC) Receives $22.86 Consensus Target Price from Analysts

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $22.86.

A number of brokerages recently issued reports on DOC. Scotiabank lifted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a report on Monday, September 9th. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Evercore ISI upped their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. Citigroup raised their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Robert W. Baird boosted their price target on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th.

Healthpeak Properties Stock Performance

Shares of NYSE DOC opened at $22.33 on Friday. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26. The firm has a market cap of $15.62 billion, a P/E ratio of 46.79, a PEG ratio of 2.41 and a beta of 1.13. The stock has a fifty day moving average price of $22.17 and a two-hundred day moving average price of $21.18. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. During the same quarter last year, the firm posted $0.45 earnings per share. Healthpeak Properties’s revenue was up 25.9% compared to the same quarter last year. Research analysts forecast that Healthpeak Properties will post 1.8 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.37%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s payout ratio is currently 255.32%.

Institutional Trading of Healthpeak Properties

A number of institutional investors have recently added to or reduced their stakes in the business. HM Payson & Co. bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at $25,000. S.A. Mason LLC bought a new position in Healthpeak Properties during the third quarter valued at about $26,000. Rise Advisors LLC bought a new position in Healthpeak Properties during the third quarter valued at about $29,000. Fortitude Family Office LLC acquired a new stake in shares of Healthpeak Properties in the third quarter worth about $32,000. Finally, Barrett & Company Inc. bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $33,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.